Menu

Inhibikase Therapeutics, Inc. IKT

Full chart Compare
Set alert

Price alert · IKT

All alert types
1.55 USD -0.13 (-7.74%)

At closeNov 10, 2026, 4:00 PM EST

1.55 0.00 0.00%

After hours · Nov 10, 4:00 PM ET

1.53 Day range 1.65
1.40 52-week range 2.61
YTD
-24.39%
1 year
-2.52%

Revenue & Expenses

Other Income → Expenses: $1.06MExpenses → Gross Loss: $13.36MExpenses → Selling, General & Admin: $6.73MExpenses → Research & Development: $13.62MOther Operating Income → Expenses: $13.62MNet Loss → Expenses: $19.03MRevenue → Cost of Revenue: $260.50KOther Income$1.06MOther Operating Income$13.62MNet Loss$19.03MCost of Revenue$13.62MExpenses$33.71MGross Loss$13.36MSelling, General & Admin$6.73MResearch & Development$13.62MRevenue$260.50K

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

IKT annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
53.35M28.59M20.35M18.25M17.87M
29.79M17.21M13.62M12.03M11.36M
23.56M11.38M6.73M6.22M6.51M
-53.35M-28.59M-20.09M-18.13M-14.77M
-48.26M-27.52M-19.03M-18.05M-14.79M
-48.26M-27.52M-19.03M-18.05M-14.79M
-48.26M-27.52M-19.03M-18.05M-14.79M
-48.26M-27.52M-19.03M-18.05M-14.79M
-0.49-1.16-3.16-4.28-4.86
-0.49-1.16-3.16-4.28-4.86
-0.49-1.16-3.16-4.28-4.86
-48.26M-27.52M-19.03M-18.05M-14.77M
-48.26M-27.52M-19.03M-18.05M-14.77M
98.31M23.71M6.03M4.22M3.03M
98.31M23.71M6.03M4.22M3.03M